CLSD logo

Clearside Biomedical (CLSD) Company Overview

Profile

Full Name:

Clearside Biomedical, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 2, 2016

Indexes:

Not included

Description:

Clearside Biomedical is a biotechnology company focused on developing innovative treatments for eye diseases. They use a unique delivery system to administer medications directly to the eye, aiming to improve patient outcomes and reduce side effects. Their goal is to enhance vision and quality of life for patients.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 6, 25 Needham
Buy
Mar 6, 25 HC Wainwright & Co.
Buy
Nov 15, 24 Chardan Capital
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Needham
Buy
Oct 14, 24 Chardan Capital
Buy
Oct 10, 24 Needham
Buy
Aug 27, 24 HC Wainwright & Co.
Buy
Aug 21, 24 Chardan Capital
Buy
Aug 13, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Clearside Biomedical?
  • Does Clearside Biomedical pay dividends?
  • What sector is Clearside Biomedical in?
  • What industry is Clearside Biomedical in?
  • What country is Clearside Biomedical based in?
  • When did Clearside Biomedical go public?
  • Is Clearside Biomedical in the S&P 500?
  • Is Clearside Biomedical in the NASDAQ 100?
  • Is Clearside Biomedical in the Dow Jones?
  • When was Clearside Biomedical's last earnings report?
  • When does Clearside Biomedical report earnings?
  • Should I buy Clearside Biomedical stock now?

What is the ticker symbol for Clearside Biomedical?

The ticker symbol for Clearside Biomedical is NASDAQ:CLSD

Does Clearside Biomedical pay dividends?

No, Clearside Biomedical does not pay dividends

What sector is Clearside Biomedical in?

Clearside Biomedical is in the Healthcare sector

What industry is Clearside Biomedical in?

Clearside Biomedical is in the Biotechnology industry

What country is Clearside Biomedical based in?

Clearside Biomedical is headquartered in United States

When did Clearside Biomedical go public?

Clearside Biomedical's initial public offering (IPO) was on June 2, 2016

Is Clearside Biomedical in the S&P 500?

No, Clearside Biomedical is not included in the S&P 500 index

Is Clearside Biomedical in the NASDAQ 100?

No, Clearside Biomedical is not included in the NASDAQ 100 index

Is Clearside Biomedical in the Dow Jones?

No, Clearside Biomedical is not included in the Dow Jones index

When was Clearside Biomedical's last earnings report?

Clearside Biomedical's most recent earnings report was on Nov 12, 2024

When does Clearside Biomedical report earnings?

The next expected earnings date for Clearside Biomedical is Mar 12, 2025

Should I buy Clearside Biomedical stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions